Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network.
Anum SaeedJianhui ZhuFloyd ThomaOscar MarroquinAryan AiyerAnandita AgarwalaSalim S ViraniMartha GulatiJoon S LeeSteven ReisSamir F SabaChristie M BallantyneSuresh MulukutlaPublished in: Circulation. Cardiovascular quality and outcomes (2021)
In a real-world primary prevention cohort, over one-third of statin-eligible patients were not prescribed statin therapy. Among those receiving a statin, mean time to GDSI was ≈2 years. The consequences of nonadherence to guidelines are illustrated by greater incident ASCVD and mortality events. Further research can develop and optimize health care system strategies for primary prevention.
Keyphrases
- cardiovascular disease
- cardiovascular events
- coronary artery disease
- end stage renal disease
- healthcare
- type diabetes
- chronic kidney disease
- cardiovascular risk factors
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- risk factors
- adipose tissue
- mesenchymal stem cells
- patient reported outcomes
- cell therapy
- social media
- clinical practice
- insulin resistance
- patient reported